Lung lesions induced by intratracheal instillation of vanadium pentoxide powder in rats

T Toya1, K Fukuda, M Takaya

  • 1National Institute of Industrial Health, Kawasaki, Japan.

Industrial Health
|February 24, 2001
PubMed

Insights

Vanadium pentoxide (V2O5) powder exposure caused lung damage in rats, including inflammation and epithelial changes. These effects were dose-dependent and linked to both V2O5 particles and dissolved vanadium ions.

Area of Science:

  • Toxicology
  • Environmental Health
  • Pulmonary Pathology

Background:

  • Vanadium pentoxide (V2O5) is an industrial chemical with potential respiratory toxicity.
  • Understanding the specific mechanisms of V2O5-induced lung injury is crucial for occupational safety.

Purpose of the Study:

  • To investigate the acute toxicity and histopathological lung changes following intratracheal administration of V2O5 powder in rats.
  • To elucidate the role of V2O5 particles and dissolved vanadium ions in causing lung lesions.

Main Methods:

  • Male Sprague-Dawley rats (n=66) received intratracheal V2O5 powder at doses of 0.88, 3.0, or 13.0 mg/kg.
  • Animals were observed for 4 weeks, with lung tissues examined for histopathological changes.
  • V2O5 particle characteristics and solubility in Gamble's solution were analyzed.

Main Results:

  • Dose-dependent histopathological lung lesions were observed, including exudative inflammation and epithelial damage.
  • Alveolar macrophage injury and broncho-bronchiolar epithelial swelling/mucous degeneration were prominent findings.
  • Rat growth rate was significantly retarded in a dose-dependent manner.

Conclusions:

  • Intratracheal V2O5 powder induces significant, dose-dependent lung toxicity in rats.
  • Lung lesions are attributed to both the V2O5 particles themselves and dissolved vanadium ions.
  • Findings highlight the importance of V2O5 particle solubility in biological fluids for toxicity assessment.

Related Concept Videos